Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
23.04.25
/
50%
€103.95
Target price
23.04.26
€172.63
Performance (%)
54.44%
End price
24.04.26
€160.54
Summary
This prediction ended on 24.04.26 with a price of €160.54. The BUY prediction by The_Goldman_Sachs_Gr for Biogen Inc. saw massive gains of 54.44%. The_Goldman_Sachs_Gr has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 0.547% | 0.547% | 53.965% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $219.00 to $197.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten